These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33438097)

  • 1. Fouling Behavior during Sterile Filtration of Different Glycoconjugate Serotypes Used in Conjugate Vaccines.
    Emami P; Fallahianbijan F; Dinse E; Motevalian SP; Conde BC; Reilly K; Zydney AL
    Pharm Res; 2021 Jan; 38(1):155-163. PubMed ID: 33438097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefiltration enhances performance of sterile filtration for glycoconjugate vaccines.
    Du Z; Motevalian SP; Carillo-Conde B; Reilly K; Zydney AL
    Biotechnol Prog; 2021 Sep; 37(5):e3180. PubMed ID: 34106522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterile filtration of a multi-serotype glycoconjugate vaccine drug product.
    Du Z; Gill K; Toprani V; Zydney AL
    Biotechnol Bioeng; 2023 May; 120(5):1316-1322. PubMed ID: 36726046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scale-up issues during sterile filtration of glycoconjugate vaccines.
    Du Z; Motevalian SP; Carrillo Conde B; Reilly K; Zydney AL
    Biotechnol Prog; 2022 Jul; 38(4):e3260. PubMed ID: 35412686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filtration of a multi-serotype glycoconjugate vaccine drug product through sterilizing grade 0.2/0.22 µm pore size filters.
    Du Z; Qiu S; Gill K; Toprani V; Zydney AL
    Biotechnol J; 2024 Feb; 19(2):e2300450. PubMed ID: 38403435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basics of sterile compounding: bubble point testing.
    Thoma L
    Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein fouling during constant-flux virus filtration: Mechanisms and modeling.
    Peles J; Cacace B; Carbrello C; Giglia S; Zydney AL
    Biotechnol Bioeng; 2023 Nov; 120(11):3357-3367. PubMed ID: 37489799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a sterile filtration process for viral vaccines using a model nanoparticle suspension.
    Taylor N; Ma W; Kristopeit A; Wang SC; Zydney AL
    Biotechnol Bioeng; 2021 Jan; 118(1):106-115. PubMed ID: 32880898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of isoporous microslit silicon nitride membranes for sterile filtration applications.
    Wright E; Miller JJ; Csordas M; Gosselin AR; Carter JA; McGrath JL; Latulippe DR; Roussie JA
    Biotechnol Bioeng; 2020 Mar; 117(3):879-885. PubMed ID: 31784974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scale-up of Sterilizing-grade Membrane Filters from Discs to Pleated Cartridges: Effects of Operating Parameters and Solution Properties.
    Kumar A; Martin J; Kuriyel R
    PDA J Pharm Sci Technol; 2015; 69(1):74-87. PubMed ID: 25691716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoconjugate vaccines: some observations on carrier and production methods.
    MacCalman TE; Phillips-Jones MK; Harding SE
    Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations into the fouling mechanism of parvovirus filters during filtration of freeze-thawed mAb drug substance solutions.
    Barnard JG; Kahn D; Cetlin D; Randolph TW; Carpenter JF
    J Pharm Sci; 2014 Mar; 103(3):890-9. PubMed ID: 24549732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pore size, shear rate, and harvest time during the constant permeate flux microfiltration of CHO cell culture supernatant.
    Stressmann M; Moresoli C
    Biotechnol Prog; 2008; 24(4):890-7. PubMed ID: 19194898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding polysaccharide-protein coupling of glycoconjugate vaccines.
    Berti F
    J Biol Chem; 2022 Mar; 298(3):101755. PubMed ID: 35202656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
    Berti F; Micoli F
    Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data Mining to Determine the Influence of Fluid Properties on the Integrity Test Values.
    Thome B; Joseph B; Dassu D; Gaerke J; McBurnie L; Dixit M; Stering M; Tomlinson S; Mills S; Ferrante S; Weitzmann C
    PDA J Pharm Sci Technol; 2020; 74(5):524-562. PubMed ID: 32467178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates.
    Humpierre AR; Zanuy A; Saenz M; Garrido R; Vasco AV; Pérez-Nicado R; Soroa-Milán Y; Santana-Mederos D; Westermann B; Vérez-Bencomo V; Méndez Y; García-Rivera D; Rivera DG
    Bioconjug Chem; 2020 Sep; 31(9):2231-2240. PubMed ID: 32809806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein fouling on filtrate flux and virus breakthrough behaviors during virus filtration process.
    Suh D; Jin H; Park H; Lee C; Cho YH; Baek Y
    Biotechnol Bioeng; 2023 Jul; 120(7):1891-1901. PubMed ID: 37144573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of particle size distribution on filtration performance of cell culture medium.
    Chan K; Tomioka Y; Mok Y; Ito T
    Biotechnol Prog; 2021 May; 37(3):e3130. PubMed ID: 33491344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane fouling in sterile filtration of recombinant human growth hormone.
    Maa YF; Hsu CC
    Biotechnol Bioeng; 1996 May; 50(3):319-28. PubMed ID: 18626959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.